On July 31, 2018 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) reported that the company will host its second quarter 2018 investor conference call and webcast at 8:30 am ET on Tuesday, August 7, 2018 (Press release, Merrimack, JUL 31, 2018, View Source [SID1234528281]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The call will provide an update on Merrimack’s recent progress as well as a summary of its second quarter 2018 financial results. A press release detailing the information to be discussed on the call will be issued the morning of Tuesday, August 7, 2018. Investors and the general public are invited to listen to the call by dialing (877) 564-1301 (domestic) or (224) 357-2394 (international) five minutes prior to the start of the call and providing the passcode 6476538.

A listen-only webcast of the call will be available in the Investors section of Merrimack’s website, investors.merrimack.com, and a replay of the call will be archived there for six weeks.